Next Article in Journal
Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation
Next Article in Special Issue
Predictors of Survival in Atypical Meningiomas
Previous Article in Journal
Video-Laparoscopic versus Open Surgery in Obese Patients with Colorectal Cancer: A Propensity Score Matching Study
Previous Article in Special Issue
Are We Benign? What Can Wnt Signaling Pathway and Epithelial to Mesenchymal Transition Tell Us about Intracranial Meningioma Progression
 
 
Systematic Review

Article Versions Notes

Cancers 2021, 13(8), 1846; https://doi.org/10.3390/cancers13081846
Action Date Notes Link
article xml file uploaded 13 April 2021 09:48 CEST Original file -
article xml uploaded. 13 April 2021 09:48 CEST Update https://www.mdpi.com/2072-6694/13/8/1846/xml
article pdf uploaded. 13 April 2021 09:48 CEST Version of Record https://www.mdpi.com/2072-6694/13/8/1846/pdf
article supplementary file uploaded. 13 April 2021 09:48 CEST - https://www.mdpi.com/2072-6694/13/8/1846#supplementary
article html file updated 13 April 2021 09:50 CEST Original file -
article html file updated 5 August 2021 04:48 CEST Update -
article html file updated 25 July 2022 11:56 CEST Update https://www.mdpi.com/2072-6694/13/8/1846/html
Back to TopTop